Clinical Trials Logo

Filter by:
NCT ID: NCT01608672 Completed - Glabellar Lines Clinical Trials

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Start date: April 1, 2012
Phase:
Study type: Observational

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

NCT ID: NCT01608412 Recruiting - Clinical trials for Kidney Transplant Recipients

A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

Start date: February 2012
Phase: Phase 4
Study type: Interventional

The study hypotheses to be tested in this study are: - Conversion to everolimus at 3 months post-transplantation is safe and effective; - Accurate noninvasive molecular diagnostic tests can replace biopsy at 3 months pre-conversion (for the diagnosis of subclinical cellular and/or humoral rejection, tissue fibrosis and calcineurin inhibitor-induced nephrotoxicity) in kidney transplant recipients; - Follow-up biopsy at 12 months post-conversion (for the diagnosis of tissue fibrosis) can be replaced with accurate noninvasive molecular diagnostic tests in kidney transplant recipients.

NCT ID: NCT01607060 Completed - Constipation Clinical Trials

Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.

Start date: September 2008
Phase: Phase 3
Study type: Interventional

MAIN FEATURES OF THE STUDY: therapeutic intervention. Constipation is a frequent complication in critical ill patients. The disaccharide lactulose has a laxative osmotic activity. Given the scant evidence and the potential risk associated with constipation in seriously ill patients, this study aims to assess the impact of laxative therapy in the prognosis of critically ill patients. Study hypothesis: Constipation is part of the clinical spectrum of intestinal dysfunction and if treated can result in improved prognosis for critically ill patients.

NCT ID: NCT01605981 Withdrawn - Clinical trials for Chronic Myeloid Leukemia (CML)

Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.

MACS1881
Start date: February 2014
Phase: Phase 4
Study type: Interventional

This is an open label, non randomized, prospective, multicenter, phase II clinical trial evaluating nilotinib 400 mg BID for the treatment of newly diagnosed CML-AP patients. Patients enrolled into the study will receive 400mg of nilotinib, orally, twice daily (800mg/day)

NCT ID: NCT01604681 Recruiting - Hypertension Clinical Trials

Supplementation With Flaxseed Oil in the State of Rio de Janeiro

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of supplementation with flaxseed oil combined with a nutritional counseling in reducing cardiovascular risk factors in homocysteine , biomarkers of inflammation, oxidative stress, improving quality of life and cognitive decline in hypertensive and dyslipidemic genotyped for the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene.

NCT ID: NCT01603940 Completed - Hypertension Clinical Trials

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

CONTROL
Start date: May 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare losartan and benazepril in diabetic patients whose high blood pressure is not controlled by amlodipine and its relationship to statin current use.

NCT ID: NCT01603498 Completed - Trismus Clinical Trials

Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar Surgery

Start date: April 2011
Phase: N/A
Study type: Interventional

The main aim of the present study was to investigate the effect of preemptive dexamethasone and methylprednisolone to prevent pain, swelling and limitation in mouth opening following third molar extraction.

NCT ID: NCT01603030 Not yet recruiting - Clinical trials for Eye Infection/Inflammation Other

Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation

Start date: June 2012
Phase: Phase 3
Study type: Interventional

This is a Unicentric, double-blind, randomized, two-arm, parallel-group study to demonstrate the efficacy of moxifloxacin/prednisolone acetate fixed combination compared with individual administration of moxifloxacin + acetate Prednisolone Eye drops in Prevention of Post Operative Inflammation and Infection in LASIK surgery.

NCT ID: NCT01602380 Active, not recruiting - Clinical trials for Hormone Receptor Positive Breast Cancer

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

FALCON
Start date: October 17, 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast cancer who have not had prior hormonal treatment.

NCT ID: NCT01602224 Completed - Multiple Myeloma Clinical Trials

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate an investigational drug called tabalumab in participants with Multiple Myeloma (MM) who have tried at least one other therapy in the past. Tabalumab will be given in combination with standard doses of two other drugs that are often used to treat MM. Study doctors will collect information about the effectiveness and side effects of this therapy.